This is great news! It means Dr. Levitt will be giving further guidance regarding Squalamine in the 2nd quarter. Notice it is for opthalmic indications (PLURAL), including the treatment of wet AMD. Looks like they intend on treating other various forms of eye diseases.
Market Data 
Markets 
AI
